{"rows":[{"id":4109,"title":"Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanisms","authors":"Martina Colognesi, Daniela Gabbia, Anna Signor, Miles Sarill, Lucia Centofanti, Andrea Rinaldi, Luciano Cascione, Sara Nunziata, Marco Banzato, Andrea Mattarei, Giovanna Finzi, Sonia Sonda, Diana Pendin, Ilaria Zanotto, Stefano Comai, Gianfranco Pasut, Abdullah Alajati, Miriam Saponaro, Loredana Bucciarelli, Maria Elena Lunati, Andrea Alimonti, et al.","journal":"Repository for Publications and Research Data (ETH Zurich)","publication_date":"2026-01-20","publication_year":2026,"doi":"10.3929/ethz-c-000793359","pubmed_id":null,"openalex_id":"https://openalex.org/W7131103137","source_url":"http://hdl.handle.net/20.500.11850/793359","substance_tags":"psilocybin","topic_tags":"Pharmacology,Mechanism of Action,Receptor Pharmacology,Toxicity","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:36","last_checked":"2026-08-09 08:25:12","bibtex":null,"source_record_id":"DOI:10.3929/ethz-c-000793359","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.3929/ethz-c-000793359","source_url":"http://hdl.handle.net/20.500.11850/793359","doi":"10.3929/ethz-c-000793359","pmid":"","publication_date":"2026-01-20","importer_version":"2.1.3","text_redistributed":false}},{"id":4026,"title":"Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled Settings","authors":"Kurt Stocker, Matthias Hartmann, Frederick S. Barrett, William A. Richards, Nathan D. Sepeda, Laura Ley, Anna M. Becker, Friederike Holze, Matthias E. Liechti","journal":"Repository for Publications and Research Data (ETH Zurich)","publication_date":"2026-04-30","publication_year":2026,"doi":"10.3929/ethz-c-000799490","pubmed_id":null,"openalex_id":"https://openalex.org/W7160627143","source_url":"http://hdl.handle.net/20.500.11850/799490","substance_tags":"psilocybin","topic_tags":"Chronic Pain,Mystical Experience,Healthy Volunteers,Toxicity","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:35","last_checked":"2026-08-09 08:25:08","bibtex":null,"source_record_id":"DOI:10.3929/ethz-c-000799490","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"http://hdl.handle.net/20.500.11850/799490","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.3929/ethz-c-000799490","source_url":"http://hdl.handle.net/20.500.11850/799490","doi":"10.3929/ethz-c-000799490","pmid":"","publication_date":"2026-04-30","importer_version":"2.1.3","text_redistributed":false}}],"total":2,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Repository for Publications and Research Data (ETH Zurich)","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}